AGREEMENT AND PLAN OF MERGER BY AND AMONG LOGICBIO THERAPEUTICS, INC. ALEXION PHARMACEUTICALS, INC. AND CAMELOT MERGER SUB, INC. Dated as of October 3, 2022Merger Agreement • October 3rd, 2022 • LogicBio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
This AGREEMENT AND PLAN OF MERGER, dated as of October 3, 2022 (this “Agreement”), is entered into by and among LogicBio Therapeutics, Inc., a Delaware corporation (the “Company”), Alexion Pharmaceuticals, Inc., a Delaware corporation (“Parent”), and Camelot Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub” and, collectively with the Company and Parent, the “Parties”).
AGREEMENT AND PLAN OF MERGER by and among DAEGIS INC., OPEN TEXT CORPORATION and COMPANY D MERGER SUB INC. October 8, 2015Merger Agreement • October 14th, 2015 • Daegis Inc. • Services-prepackaged software • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated October 8, 2015, is entered into by and among DAEGIS INC., a Delaware corporation (the “Company”), OPEN TEXT CORPORATION, a Canadian corporation (“Parent”), and COMPANY D MERGER SUB INC., a Delaware corporation and an indirect wholly-owned subsidiary of Parent (“Merger Sub”).
AGREEMENT AND PLAN OF MERGER DATED AS OF NOVEMBER 8, 2012 BY AND AMONG SUN PHARMACEUTICAL INDUSTRIES LIMITED MERGER SUB AND DUSA PHARMACEUTICALS, INC.Merger Agreement • November 8th, 2012 • Dusa Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
Agreement and Plan of Merger (this “Agreement”), dated as of November 8, 2012, among SUN PHARMACEUTICAL INDUSTRIES LIMITED, a corporation organized under the laws of India (“Parent”), Caraco Acquisition Corporation, a New Jersey corporation and indirect wholly-owned subsidiary of Parent (“Merger Sub”), and DUSA PHARMACEUTICALS, INC., a New Jersey corporation (the “Company”). Capitalized terms not otherwise defined herein shall have the meaning set forth in Exhibit A attached hereto.